MarketInOut Stock Screener Log In | Sign Up

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

HKSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 14:56
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeHKSE
Market Capitalization2,534.49 mln
Float255 mln
Earnings Date08/11/2025

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.34
Reliable

Relative Strength

73 / 100
Outperforming

Debt / Equity

0.01
Debt-free

Pre-Tax Margin

-14%
Loss-making

ROE

-4.36
Negative

Business Description

Founded in 1996 and headquartered in Shanghai, China, Fudan-Zhangjiang Bio-Pharmaceutical develops, manufactures, and sells a range of medical drugs across the country. The company's products include treatments based on photodynamic technology, a liposomal cancer drug sold under the Libord brand, genetically engineered medicines, and oral solid-form drugs.

Key Fundamentals

EPS-0.13
ROE-4.36
RPS0.76
ROIC-10.46
ROA-3.92
Interest Cover-234
EBITDA, mln-21.20
EV / EBITDA-62.83
EV / EBIT-12.77
Revenue, mln749
EV / Revenue1.78

Quote Details

Last 2.47
Change 0.07 (2.92%)
Open 2.45
Volume 600,000
Turnover 1,482,000
Average Volume 819,571

Financial Ratios

Pre-Tax Profit Margin-14
Leverage Ratio1.12
Current Ratio6.53
Price / Book1.10
Price / Tangible Book1.13
Price / Cash Flow46.11
Price / Free Cash Flow16.89
Debt / Equity0.01
Price / Sales3.65

Financial Strength

Altman Z-Score6.64
Piotroski F-Score 6 / 9
Beneish M-Score-3.34
Price to Intrinsic Value1.03
Shiller PE Ratio26.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.41% 71 / 100   
1 Month -5.36% 54 / 100   
2 Months 2.92% 75 / 100   
6 Months -11.47% 59 / 100   
1 Year -23.77% 45 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog